Kapiva revenue FY26: ₹464 crore, net loss ₹72 crore
Kapiva revenue rises 36% to ₹464 crore
By Abha Lohia ·
Kapiva revenue
Kapiva reported revenue of ₹464 crore in FY26, with a net loss of ₹72 crore. Reported 26 October 2026.
| Revenue (FY26) | ₹464 crore |
|---|---|
| Net loss (FY26) | ₹72 crore |
Kapiva: revenue and funding and every story →
- Kapiva, started in 2015, makes Ayurveda-based health products aimed at blood sugar, liver care, hormones, stamina and fitness
- Operating revenue grew from ₹340 crore to ₹464 crore in FY26, while the yearly loss stayed steady at about ₹72 crore
- Advertising took nearly half of all spending, and the company is aiming for EBITDA profit by the fourth quarter of FY27
What happened
- Kapiva's revenue from operations reached ₹464 crore in FY26.
- That is up 36.5% from ₹340 crore a year earlier.
- Total income including other earnings was ₹474 crore.
- The yearly loss stayed near ₹72 crore.
- Spending rose 31% to ₹547 crore.
Why it matters
- The brand is growing fast after a 50% jump the year before.
- Margins improved once stock-option costs are set aside.
- It targets EBITDA (operating profit) positive by Q4 FY27.
The business
- Kapiva sells Ayurvedic wellness products.
- Categories include diabetes care, liver health and sports nutrition.
- Product sales are its only source of operating revenue.
In numbers
₹464 croreOperating revenue · FY26
₹260 croreAdvertising spend · FY26
₹72 croreLoss · FY26
What happens next
- Reach EBITDA profit by Q4 FY27.
Terms in this story
- EBITDA: EBITDA is a company's operating earnings before interest, tax, depreciation and amortisation. It is a useful shortcut for how the core business performs, but it is not the same as profit, and adjusted EBITDA can hide real costs.
Everything on Kapiva → · All startup news on 26 October 2026 →
Is this Kapiva? Get your “Featured on StopDown” badge →